This is a proposal for Signify Research’s 2020 report on the global market for AI in drug development & clinical trials to be published in October 2020.

Key issues to be addressed:

  • How large is the global market for AI in drug development in terms of revenue and how will this change over the next five years?
  • How does the market break out in terms of applications for information synthesis, drug design and clinical trials?
  • How does the market break out in terms of clinical areas (oncology, neurology, infectious disease, other)?
  • How is the market split between licencing models?
  • What are the main drivers behind each market segment?
  • Who are the leading vendors and what is needed to stay competitive?

Report ContentAI in Drug Report Content


  • Identify the products and end-markets driving growth
  • Review the market drivers and barriers for growth
  • Quantitative analysis of market size and forecast growth


  • Market share estimates for the leading vendors
  • Detailed profiles of selected vendors, with SWOT analysis for each
  • Identify potential partners and acquisition targets


  • Market analysis for AI applications in information and disease models, drug design & optimisation, preclinical & clinical trials
  • Impact of advanced machine learning and deep learning
  • Influence of next generation DNA sequencing and processing technologies


  • Review go-to-market strategies
  • Analysis and insights to support your strategy and business planning
  • Product pricing and software delivery strategies
Related Content